[1]赵隽,温松,于法明,等.含Sushi重复蛋白X连锁2基因敲除对肺腺癌A549细胞生物学特性的影响[J].新乡医学院学报,2022,39(10):901-906.[doi:10.7683/xxyxyxb.2022.10.001]
　ZHAO Jun,WEN Song,YU Faming,et al.Effect of Sushi repeat containing protein,X-linked 2 gene knockout on the biological characteristics of lung adenocarcinoma A549 cells[J].Journal of Xinxiang Medical University,2022,39(10):901-906.[doi:10.7683/xxyxyxb.2022.10.001]
点击复制

含Sushi重复蛋白X连锁2基因敲除对肺腺癌A549细胞生物学特性的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年10
页码:
901-906
栏目:
基础研究
出版日期:
2022-10-05

文章信息/Info

Title:
Effect of Sushi repeat containing protein,X-linked 2 gene knockout on the biological characteristics of lung adenocarcinoma A549 cells
作者:
赵隽1; 2; 温松1; 2; 于法明2; 姜东亮1; 2; 李慎柯1; 2
（1.新乡医学院，河南　新乡　453003；2.濮阳市油田总医院呼吸科，河南　濮阳　457001）
Author(s):
ZHAO Jun1; 2; WEN Song1; 2; YU Faming2; JIANG Dongliang1; 2; LI Shenke1; 2
(1.Xinxiang Medical University,Xinxiang 453003,Henan Province,China;2.Department of Respiratory,Puyang Oilfield General Hospital,Puyang 457001,Henan Province,China）
关键词:
含Sushi重复蛋白X连锁2; 基因敲除; 肺腺癌; A549细胞; 生物学特性
Keywords:
Sushi repeat containing protein; X-linked 2; gene knockout; lung adenocarcinoma; A549 cell; biological characteristic
分类号:
R734.2
DOI:
10.7683/xxyxyxb.2022.10.001
文献标志码:
A
摘要:
目的　探讨含Sushi重复蛋白X连锁2（SRPX2）基因敲除对肺腺癌人类肺泡基底上皮细胞A549细胞生物学特性的影响。方法　根据是否敲除SRPX2基因将对数生长期的A549细胞分为对照组和敲除组，敲除组细胞采用成簇规律间隔短回文重复序列（CRISPR）-CRISPR 相关蛋白9基因编辑技术敲除SRPX2基因，对照组细胞常规传代培养。采用聚合酶链式反应法、琼脂糖凝胶电泳以及DNA测序验证是否成功敲除SRPX2基因。采用流式细胞术检测2组细胞周期，细胞计数试剂盒法检测2组细胞增殖情况，Transwell小室实验检测2组细胞迁移能力。结果　琼脂糖凝胶电泳及DNA测序结果均显示敲除组细胞成功敲除68 bp SRPX2基因部分序列。培养24 h时，敲除组G0/G1及S期细胞所占比例显著低于对照组，G2/M期细胞所占比例显著高于对照组（P<0.05）；培养48 h时，敲除组S期细胞所占比例显著低于对照组，G2/M期细胞所占比例显著高于对照组（P<0.05）；培养48 h时，2组G0/G1期细胞所占比例比较差异无统计学意义（P>0.05）。培养0、24、48、72、96 h 时，对照组和敲除组细胞的增殖能力随时间的延长均呈升高趋势（F=244.463、87.198,P<0.05）；培养0、24、48、72、96 h 时，2组细胞的增殖能力比较差异均无统计学意义(P>0.05)。培养24 h时，对照组和敲除组迁移细胞数分别为(24.200±3.899)、(6.800±1.304)个；培养48 h时，对照组和敲除组迁移细胞数分别为(92.200±6.419)、(48.800±2.280)个；培养24、48 h时，敲除组迁移细胞数显著少于对照组（t=9.464、14.247，P<0.05）。结论　敲除肺腺癌A549细胞中SRPX2基因能显著抑制细胞的迁移、阻滞细胞周期，SRPX2基因可能成为肺腺癌治疗的新靶点。
Abstract:
Objective　To investigate the effect of Sushi repeat containing protein,X-linked 2 (SRPX2) gene knockout on the biological characteristics of lung adenocarcinoma human alveolar basal epithelial cells A549.Methods　A549 cells in logarithmic growth phase were divided into the control group and the knockout group according to whether the SRPX2 gene was knocked out.The SRPX2 gene in the cells in the knockout group was knocked out by clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 gene editing technology,and the cells in the control group were routinely subcultured.Whether the SRPX2 gene was successfully knocked out was verifyed by polymerase chain reaction,agarose gel electrophoresis and DNA sequencing.The cell cycle in the two groups was detected by flow cytometry.The cell proliferation in the two groups was detected by cell counting kit.The cell migration ability in the two groups was detected by Transwell assay.Results　The results of agarose gel electrophoresis and DNA sequencing showed that the cells in the knockout group were successfully knocked out the 68 bp partial sequence of SRPX2 gene.When cultured for 24 h,the ratio of cells in G0/G1 and S phase in the knockout group were significantly lower than those in the control group,and the ratio of cells in G2/M phase was significantly higher than that in the control group (P<0.05).When cultured for 48 h,the ratio of cells in S phase in the knockout group was significantly lower than that in the control group,and the ratio of cells in G2/M phase was significantly higher than that in the control group (P<0.05);there was no significant difference in the ratio of cells in G0/G1 phase between the two groups (P>0.05).When cultured for 0,24,48,72 and 96 h,the proliferation ability of cells in the control group and knockout group increased with time (F=244.463,87.198;P<0.05);at 0,24,48,72 and 96 h of culture,there was no significant difference in the proliferation ablitity of cells between the two groups (P>0.05).When the cells cultured for 24 h,the number of migrating cells in the control group and the knockout group were 24.200±3.899 and 6.800±1.304,respectively;when the cells cultured for 48 h,the number of migrating cell in the control group and the knockout group were 92.200±6.419 and 48.800±2.280,respectively;when cultured for 24 h and 48 h,the number of migrating cells in the knockout group was significantly less than that in the control group (t=9.464,14.247;P<0.05).Conclusion　Knockout of SRPX2 gene in lung adenocarcinoma A549 cells can significantly inhibit cell migration and arrest cell cycle.SRPX2 gene may become a new target for lung adenocarcinoma therapy.

参考文献/References:

［1］　DURUISSEAUX M,ESTELLER M.Lung cancer epigenetics:from knowledge to applications［J］.Semin Cacer Biol,2018,51:116-128.
［2］　CHEN W,LI H,SUN K X,et al.Cancer incidence and mortality in China,2014［J］.Chin J Cancer Res,2018,40(1):5-13.
［3］　HERBST R S,MORGENSZTERN D,BOSHOFF C.The biology and management of non-small cell lung cancer［J］.Nature,2018,553(7689):446-454.
［4］　KUROSAWA H,GOI K,INUKAI T,et al.Two candidate downstream target genes for E2A-HLF［J］.Blood,1999,93(1):321-332.
［5］　TANAKA K,ARAO T,MAEGAWA M,et al.SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion［J］.Int J Cancer,2009,124(5):1072-1080.
［6］　GAO Z,ZHANG J,BI M,et al.SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer［J］.Int J Clin Exp Pathol,2015,8(5):4791.
［7］　LIN X,CHANG W,WANG Y,et al.SRPX2,an independent prognostic marker,promotes cell migration and invasion in hepatocellular carcinoma［J］.Biomed Pharmacother,2017,93:398-405.
［8］　李婷,彭波.SRPX2 在胃癌中的表达及对细胞侵袭的影响［J］.中国现代医学杂志,2017,27(28):36-40.
LI T,PENG B.Expression of SRPX2 in human gastric carcinoma and its role in cell invasion［J］.Chin J Mod Med,2017,27(28):36-40.
［9］　周跃,刘揆亮,吴静.细胞外基质蛋白 SRPX2 对结肠癌 SW480 细胞生物学行为的影响［J］.中华实验外科杂志,2014,31(12):2748-2750.
ZHOU Y,LIU K L,WU J.Effect of extracellular matrix protein SRPX2 on the biological behavior of colon cancer cell line SW480［J］.Chin J Exp Surg,2014,31(12):2748-2750.
［10］　LIU K,FAN J,WU J.Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways［J］.Drug Discov Ther,2017,11(4):212-217.
［11］　TSIM S,O DOWD C A,MILROY R,et al.Staging of non-small cell lung cancer (NSCLC):a review［J］.Respir Med,2010,104(12):1767-1774.
［12］　LEE J,LEE K,IM Y,et al.Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma［J］.Ann Thorac Surg,2005,80(4):1170-1175.
［13］　LIU H,HUNG S,HUANG C,et al.Esophagectomy for locally advanced esophageal cancer,followed by chemoradiotherapy and adjuvant chemotherapy［J］.World J Gastroenterol,2005,11(34):5367.
［14］　SHIOZAKI A,YAMAGISHI H,ITOI H,et al.Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongsthe postoperative survival of patients with esophageal cancer［J］.Oncol Rep,2005,13(4):667-672.
［15］　LEE P C,PORT J L,PAUL S,et al.Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases［J］.Ann Thorac Surg,2009,88(1):186-193.
［16］　ANDO N,IIZUKA T,IDE H,et al.Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus:a Japan Clinical Oncology Group Study—JCOG9204［J］.J Clin Oncol,2003,21(24):4592-4596.
［17］　KRISHNA R,MAYER L D.Multidrug resistance (MDR) in cancer:mechanisms,reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs［J］.Eur J Pharm Sci,2000,11(4):265-283.
［18］　TANG H,ZHAO J,ZHANG L,et al.SRPX2 enhances the epithelial：mesenchymal transition and temozolomide resistance in glioblastoma cells［J］.Cell Mol Neurobiol,2016,36(7):1067-1076.
［19］　NOOTER K,KOK T,BOSMAN F T,et al.Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy［J］.Eur J Cancer,1998,34(1):81-86.
［20］　WU C,HSIEH C,WU Y.The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy［J］.Mol Pharm,2011,8(6):1996-2011.
［21］　张孟.SRPX2 对食管癌细胞生物学特性及其临床预后相关性的研究［D］.郑州:郑州大学,2018.
ZHANG M.The biological influence and clinical impact of SRPX2 on esophageal cancer［D］.Zhengzhou:Zhengzhou University,2018.
［22］　HONG X,ZHAO H,HE C.Knockdown of SRPX2 inhibits the proliferation,migration,and invasion of prostate cancer cells through the PI3K/Akt/Mtor signaling pathway.［J］.J Biochem Mol Toxicol,2018:e22237.
［23］　LIN X,CHANG W,WANG Y,et al.SRPX2,an independent prognostic marker,promotes cell migration and invasion in hepatocellular carcinoma［J］.Biomed Pharmacother,2017,93:398-405.
［24］　PATEL L R,CAMACHO D F,SHIOZAWA Y,et al.Mechanisms of cancer cell metastasis to the bone:a multistep process［J］.Future Oncol,2011,7(11):1285-1297.
［25］　LI G,LI L,SUN Q,et al.MicroRNA-3200-5p promotes osteosarcoma cell invasion via suppression of BRMS1［J］.Mol Cell,2018,41(6):523.

相似文献/References:

[1]管丽红,贾紫森,林俊堂.规律成簇间隔短回文重复-相关核酸内切酶9技术在基因组编辑和基因转录调控中的应用[J].新乡医学院学报,2021,38(1):001.[doi:10.7683/xxyxyxb.2021.01.001]

更新日期/Last Update: 2022-10-05